Hello, Fool! | Login | Signup | My Fool
Sep 5, 2008 3:53 PM ET | Site Changes | Help
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
View All Commentary (AVII)
Recs
gzulauf1 (34.75) Submitted: 3/09/07 5:45 PM : Start Price: $2.45 AVII Score: -41.45
Risky, very promising technology, questionable management.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK